Optimal concentration of Lugol's solution for detecting early esophageal carcinoma: A randomized controlled trial.

Jun-Yan QuYan LiGuan-Qun LiuZhen LiNing ZhongMing-Ming ZhangYue-Yue LiTao YuXue-Feng LuLi-Xiang LiHan LiuQing-Qing QiYan Qing Li Xiu-Li Zuo

Published in: Journal of gastroenterology and hepatology (2023)

The study indicates that 0.6% might be the optimal concentration of Lugol's solution for early detection and delineation of ESCC, considering minimal mucosal injury and satisfied image. The registry of clinical trials: ClinicalTrials.gov (NCT03180944).

Keyphrases

clinical trial
randomized controlled trial
deep learning
solid state
machine learning
phase ii
study protocol
open label